Enochian Biosciences, Inc.

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Enochian Biosciences, Inc. (NASDAQ: ENOB) resulting from allegations that Enochian BioSciences may have issued materially misleading business information to the investing public.

If you purchased Enochian BioSciences securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Enochian BioSciences securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On May 25, 2022, during trading hours, the U.S. Department of Justice (DOJ) announced that Serhat Gumrukçu, the inventor and co-founder of Enochian BioSciences, had been arrested and charged in a murder-for-hire conspiracy.

On this news, Enochian BioSciences’s stock fell $2.17, or 37%, to close at $3.70 per share on May 25, 2022, on unusually heavy trading volume, damaging investors

Then, on June 1, 2022, market analyst Hindenburg Research published a report regarding Enochian BioSciences which is entitled “Miracle Cures and Murder For Hire: How A Spoon-Bending Turkish Magician Built A $600 Million Nasdaq-Listed Scam Based On A Lifetime Of Lies[.]” The report noted that the individual in whose murder Gumrukçu was implicated, Gregory Davis, “was murdered … just 19 days before Gumrukcu was scheduled to appear in court to defend himself against felony fraud allegations related to a 2016 deal with Davis” and that “[f]ederal prosecutors argued that the prospective merger deal that eventually resulted in Enochian going public served as a key motive for the murder.” The report also stated that “[u]nbeknownst to investors (but known to Enochian’s senior leadership) Gumrukcu’s latest arrest for a murder conspiracy is simply the most recent in a string of alleged crimes by Gumrukcu,” who “was arrested based on accusations of falsely posing as a doctor” in his native Turkey in 2012 and “[i]n February 2017, Gumrukcu was arrested by authorities after the State of California accused him of a slew of white-collar crimes, including fraud, identity theft, and check kiting – a total of 14 felonies.” The report further states that “[w]e have been unable to find any jurisdiction in which Gumrukcu is licensed as a medical doctor” and that “Gumrukcu looks to have purchased a fake Russian medical degree on the black market[.]”

On this news, Enochian’s stock fell $1.49, or 28% to close at $3.76 per share on June 1, 2022, damaging investors.

Follow us on:
Company Name: Enochian Biosciences, Inc.
Stock Symbol: ENOB
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top